Our research strengthens the role of the synaptic proteins Ng and α-Syn as biomarkers of synaptic dysfunction, and highlights the potential of the Aβ42/Ng ratio as a reliable biomarker for the early diagnosis of AD. Here, NRGN is linked to Alzheimer disease.